EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd.
Home
Technology
全部
Engineering expression platform
Antibody Humanization
Antibody Affinity Maturation
Phage Display Antibody Library
Bispecific Antibody
CAR-T
About Us
全部
Corporate Honors
Introduction
Team
History
Product
全部
Drug Discovery
Scientific research products
Project cooperation
Alpaca natural nanoantibody phage display library
Alpaca antigen injection and alpaca blood collection
Antibody customization
Antibody humanization
maturation of antibody affinity
Human natural antibody phage display library
YK012
Diagnostic and therapeutic neutralizing antibodies against COVID-19
News
Job
Contact
中文简体
Home
News
The "patent authorization of bispecific antibody" was approved
2020-02-10 09:53:05
admin
2
Previous
: Special fund support for epidemic prevention scientific research and emergency production in Haidian District in 2020
Next
: The first batch of new technology enterprises to fight against COVID-19 epidemic in Zhongguancun
